Figure 2.
Selection of OAC for stroke prevention in patients with AF and without a contraindication to systemic anticoagulation. *Subject to interpretation of guidelines and prescribing information; the latest US and European guidelines are not consistent with regards to CHA2DS2-VASc score, and this figure primarily reflects the US recommendations. See text for details. CKD, chronic kidney disease; MS, mitral stenosis.
